Company

Convoke

Biotech software startup building an AI workspace to automate knowledge work in pharmaceutical drug development, focused on planning, regulatory document preparation, and information synthesis

Healthcare & Biotech

People

Alex Telfordco-founder

Funding History

Aug 19, 2025Seed

Convoke raised an $8.6M seed round led by Kleiner Perkins. The company is building an AI workspace to automate knowledge work in drug development, focused on planning and preparation phases rather than clinical trial execution.

8.6M

Investors

Kleiner Perkins

News

Interviews (1)

Convoke raises $8.6M seed from Kleiner Perkins to automate drug development planning with AI

19 Aug 2025